Thermo Fisher Scientific (TMO) Net Cash Flow (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Net Cash Flow for 18 consecutive years, with -$6.7 billion the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$6.7 billion, down 7202.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (up 5.82% YoY), and the FY2025 annual result was $5.6 billion, up 240.49% from the prior year.
• Net Cash Flow was -$6.7 billion for Q1 2026 at Thermo Fisher Scientific, down from $7.9 billion in the prior quarter.
• Over five years, Net Cash Flow peaked at $7.9 billion in Q4 2025 and troughed at -$6.7 billion in Q1 2026.
• Average Net Cash Flow over 5 years is -$73.1 million, with a median of -$356.0 million recorded in 2024.
• Year-over-year, Net Cash Flow jumped 2311.8% in 2025 and tumbled 7202.13% in 2026.
• Over 5 years, Net Cash Flow stood at $5.4 billion in 2022, then tumbled by 64.15% to $1.9 billion in 2023, then slumped by 118.55% to -$356.0 million in 2024, then surged by 2311.8% to $7.9 billion in 2025, then plunged by 184.79% to -$6.7 billion in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$6.7 billion in Q1 2026, $7.9 billion in Q4 2025, and -$2.5 billion in Q3 2025.